Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Ana Alfonso-Piérola

Has grant

MD, PhD

Clinica Universidad de Navarra

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Recent Grants

Grant: Open

UMBRELLA-SUMMA Legacy: Unified platforM for a Better integRal Evaluation of myeLodyspLastic syndromes in spAin-Strategy for Unraveling personalized genoMic Medicine in public heAlth system incorporating patient reported outcomes.

Open Date: 2025-01-01

Close Date: 2026-12-01

Grant: Close

Predisposición Germinal a Síndromes Mielodisplásicos en Adultos: Ampliando la Precisión Diagnóstica y la Evidencia de Patogenicidad.

Open Date: 2023-06-01

Close Date: 2025-05-01

Grant: Close

Caracterización de la heterogeneidad molecular de la leucemia mieloide aguda con cambios relacionados con la mielodisplasia: identificación de nuevas estrategias terapéuticas

Open Date: 2023-01-01

Close Date: 2025-12-01

Grant: Close

Contratos Juan Rodes 2019

Open Date: 2020-04-01

Close Date: 2024-04-01

Grant: Close

Contratos Rio Hortega 2017

Open Date: 2018-04-01

Close Date: 2020-04-01

Articles (20)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (16)

ISABEL CANO FERRI

Instituto de Investigación Sanitaria La Fe

SPAIN

Ana Alfonso-Piérola

Research Interests

Explore related searches

Recent Grants

Articles (20)

Integrated Single-Cell and Spatial Multi-Omics of Clonal Precursors and Immune Niches in Germinal Center Lymphomas

A phase 1, first‐in‐human, dose‐escalation study of JNJ‐74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS

Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study.

Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry

Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances

Hematopoietic Stem Cell Hierarchies as Novel Biomarkers of Drug Response in Myelodysplastic Syndromes and Acute Myeloid Leukemia

From Sanger to Oxford Nanopore MinION Technology: The Impact of Third-Generation Sequencing on Genetic Hematological Diagnosis

First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome

Epigenetic-based differentiation therapy for Acute Myeloid Leukemia

Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma

Myelodysplastic neoplasms,Neoplasias mielodisplásicas

Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide

Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia

Severe laryngeal edema after CAR‐T cell treatment in a patient with multiple myeloma: A case report

Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study

Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia.

CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

Collaborators (16)

ISABEL CANO FERRI

Jordi Esteve Reyner

Sara Villar

ROSA MARIA AYALA DIAZ

Jenny O'Nions

Luca Lanino

Iria Vázquez Urio

Rebeca Rodríguez-Veiga

Ana Pérez Ruiz

Garcia-Foncillas J

Secundino Fernández

Fermin Sanchez-Guijo

Harriet Walter

Emmanuel GYAN

Ramón Robledano Soldevilla

Maher Abdul-Hay

Make your next move.